This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bauer, L. A.
Right arrow Articles by Hooton, T. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bauer, L. A.
Right arrow Articles by Hooton, T. M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Antibiotics
Hazardous Substances DB
*CIPROFLOXACIN
*PROCAINAMIDE

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, April 2005, p. 1649-1651, Vol. 49, No. 4
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.4.1649-1651.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Levofloxacin and Ciprofloxacin Decrease Procainamide and N-Acetylprocainamide Renal Clearances

Larry A. Bauer,1,2* Douglas J. Black,1 Jennifer S. Lill,3 Julie Garrison,3 Vidmantas A. Raisys,2 and Thomas M. Hooton4

Department of Pharmacy, University of Washington, Seattle, Washington,1 Department of Laboratory Medicine, University of Washington, Seattle, Washington,2 Department of Pharmacy Services, University of Washington, Seattle, Washington,3 Department of Medicine, University of Washington, Seattle, Washington4

Received 3 June 2004/ Returned for modification 25 July 2004/ Accepted 17 October 2004

Ten healthy adults participated in a randomized, crossover drug interaction study testing procainamide only, procainamide plus levofloxacin, and procainamide plus ciprofloxacin. During levofloxacin therapy, most procainamide and N-acetylprocainamide (NAPA) pharmacokinetic parameters, including decreased renal clearances and renal clearance/creatinine clearance ratios, changed (P < 0.05). During ciprofloxacin treatment, only procainamide and NAPA renal clearances decreased significantly.

* Corresponding author. Mailing address: Department of Pharmacy, Box 357630, University of Washington, Seattle, WA 98195. Phone: (206) 685-2713. Fax: (206) 543-3835. E-mail: labauer{at}u.washington.edu.

Antimicrobial Agents and Chemotherapy, April 2005, p. 1649-1651, Vol. 49, No. 4
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.4.1649-1651.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.





Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»